Sektor DaShenLin Pharmaceutical Group Co., Ltd.
Aktien
A2N318
CNE100002RG2
603233
Handel - Medikamente
|
Schlusskurs
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 16.15 CNY | +0.50% |
|
-6.00% | -8.34% |
| 24.04. | Dashenlin Pharma: Gewinn klettert im ersten Quartal um 11% | MT |
| 24.04. | Dashenlin Pharma: Gewinn springt 2025 um 35% nach oben, Umsatz steigt um 4% | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.50% | -6.00% | -7.24% | -10.82% | -8.34% | +1.25% | -42.28% | -54.81% | - | 2.72 Mrd. | ||
| -3.19% | -9.91% | -16.21% | -27.63% | -38.74% | -14.36% | -28.50% | -66.86% | - | 14.31 Mrd. | ||
| -0.91% | -7.37% | -15.06% | -30.43% | -35.25% | -24.83% | -26.85% | -80.83% | -42.23% | 6.81 Mrd. | ||
| -0.13% | -0.32% | +3.28% | -2.33% | -14.10% | -20.64% | -14.40% | +39.21% | +166.74% | 5.69 Mrd. | ||
| +0.61% | -8.51% | -6.57% | -18.61% | -8.38% | -15.43% | -36.67% | -40.33% | +107.31% | 3.56 Mrd. | ||
| +3.24% | +3.22% | -1.29% | -16.66% | -27.82% | -32.90% | -7.95% | +0.18% | +104.32% | 3.45 Mrd. | ||
| +0.42% | +0.42% | -2.59% | -7.43% | +0.95% | -23.65% | -44.24% | - | - | 3.32 Mrd. | ||
| -2.28% | -1.58% | +10.53% | +19.06% | +40.94% | +111.00% | - | - | - | 2.69 Mrd. | ||
| +3.90% | +1.73% | -6.08% | +1.07% | -2.51% | +7.70% | +45.25% | +6.26% | - | 1.77 Mrd. | ||
| -1.19% | +35.91% | +47.90% | +99.61% | +1.92% | -25.03% | -26.39% | -62.19% | - | 1.53 Mrd. | ||
| -0.52% | +2.12% | +3.76% | +12.54% | +35.48% | +71.97% | +111.30% | +209.49% | +326.71% | 1.16 Mrd. | ||
| -0.03% | -.--% | -.--% | -.--% | -.--% | -.--% | -.--% | -8.67% | +3.70% | 1.14 Mrd. | ||
| -0.98% | -3.86% | -6.86% | +4.93% | +3.69% | -3.85% | +5.32% | - | - | 1.07 Mrd. | ||
| -0.81% | +0.69% | -9.83% | -10.09% | -12.10% | -41.29% | -54.50% | - | - | 993 Mio. | ||
| +0.46% | -2.29% | -13.64% | -10.26% | -17.08% | +32.22% | -9.63% | - | - | 910 Mio. | ||
| -0.46% | -4.12% | -9.70% | -15.80% | -16.72% | -32.98% | -59.84% | -68.85% | -51.03% | 908 Mio. | ||
| +1.22% | -0.60% | -3.18% | +30.81% | -19.11% | -13.30% | - | - | - | 810 Mio. | ||
| -2.24% | -1.73% | -3.18% | -5.21% | -11.19% | +12.64% | -26.69% | - | - | 785 Mio. | ||
| -4.80% | -7.70% | -11.68% | -16.34% | -35.99% | -13.25% | +46.82% | +64.94% | - | 631 Mio. | ||
| +0.27% | -4.60% | -19.09% | -37.73% | -38.75% | +8.75% | -13.66% | -68.89% | - | 522 Mio. | ||
| Durchschnitt | -0.21% | -0.11% | -3.34% | -2.07% | -10.16% | -0.80% | -10.16% | -10.10% | +87.93% | 2.74 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.71% | -2.21% | -6.16% | -11.15% | -17.82% | -7.83% | -20.14% | -33.56% | +76.64% |
- Börse
- Aktien
- A2N318 Aktie
- Sektor DaShenLin Pharmaceutical Group Co., Ltd.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















